This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency Contracting Activity (DHACA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to procure various radiopharmaceuticals for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The single-award, firm-fixed-price BPA is valued at $1,900,000.00 and has a performance period from October 1, 2024 to September 30, 2029. The BPA covers the acquisition of 31 different...
The Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmalucence, Inc. as a single-award contract with a potential value of $1,250,000. The BPA aims to procure radiopharmaceutical supplies for Tripler Army Medical Center in Hawaii over a five-year period of performance from May 2021 through April 2026. Under the BPA, Pharmalucence will provide a range of radiopharmaceutical products to support nuclear medicine diagnostic imaging and related clinical...
This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Medi-Physics, Inc. to provide radiopharmaceutical supplies to Tripler Army Medical Center in Hawaii. The single award BPA has a potential value of $1.25 million and a period of performance through April 2026. The BPA facilitates orders for radiopharmaceutical supplies needed to support nuclear medicine diagnostic imaging services at Tripler Army Medical Center. As the primary provider of healthcare to...
The Blanket Purchase Agreement awarded by the Department of the Army Medical Command to Cardinal Health 414, LLC establishes a vehicle for procuring radiopharmaceutical supplies to support medical operations at Tripler Army Medical Center in Hawaii. The potential value of the BPA is $1,250,000 with a period of performance through April 2026. Four calls have been placed against the Defense Health Agency's BPAs for nuclear and radiopharmaceutical products. Cardinal Health 414, LLC was awarded...
The Blanket Purchase Agreement was awarded as a single award by the Department of the Army Medical Command to Med-Share Inc. to provide radiology services. With a potential value of $37,050, the BPA enables ordering activities within the agency to procure such services on an as-needed basis through January 13, 2026. The BPA facilitates the delivery of radiology services to various Department of the Army Medical Command facilities. As the prime contractor, Med-Share Inc. will utilize its...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sr-Services GMBH on April 1, 2023. The BPA has a potential value of $725,000 and expires on April 23, 2028. It was not subject to any set-aside requirements. The BPA aims to procure radiopharmaceuticals for use in nuclear medical services. Sr-Services GMBH will supply these products to support the Defense Health Agency's mission of providing health care services to U.S. military service members, military families,...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Advanced Accelerator Applications USA Inc., a large, foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $23.4 million single-award BPA is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of February 3, 2025. The BPA is for the procurement of LOCAMETZ and NETSPOT, two...
This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmarx Hawaii LLC on May 1, 2021. The potential value of the contract is $1,250,000. Orders may be placed through April 30, 2026 to procure radiopharmaceutical supplies in support of Tripler Army Medical Center in Hawaii. The contract aims to provide a wide range of medical isotopes and radiopharmaceuticals used in nuclear medicine imaging and therapeutic procedures. Common radiotracers such as...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sun Pharmaceutical Industries, Inc. with a potential value of $8 million. The BPA is for the delivery of radiopharmaceutical dose products and consumables to support nuclear medicine services through January 2025. No set-asides were applied to this procurement. The original solicitation sought a contractor to provide radiopharmaceuticals and related supplies necessary for diagnostic imaging and therapeutic...
This Blanket Purchase Agreement (BPA) contract was awarded by the Defense Health Agency (DHA), a defense agency, to Curium US LLC, a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $8 million single-award BPA, along with a separate $1 million BPA, facilitate the streamlined procurement of radiopharmaceuticals and related services to support healthcare operations across military treatment facilities and meet the radiopharmaceutical requirements...